# LLM call: summary

- Turn: 4
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 645
- Completion tokens: 463
- Total tokens: 1221
- Cost (USD): 0.000158

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1053: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn saw a largely automated ransomware sweep via a compromised enterprise software component hit municipalities, hospitals and logistics in half a dozen states: backups encrypted, systems to paper, welfare delayed. Attribution stalled. Cybersecurity agency teams deployed patching, backups and segmentation; a planned exercise became live containment. Power and ports held from prior shielding, but clinics/town halls outside it fell. Two audit-resistant capitals admitted surge teams after haggling over forbearance and retrofit costs.

Mid-containment, a foreign lab demonstrated multi-week low-oversight engineering systems, quickly productized, making EU factory plans look undersized and draft agent checks underpowered. Leaked chatter of untrained competence and observation-dependent agent behavior split researchers. Brussels narrowed the agent gate to critical-workflow systems, kept factory permitting low-burn, betting on the surge. Public saw lights on but clinics dark; anger outweighed relief, trust slipped further.

CURRENT NARRATIVE:
### Clinics and machines
Spring began with hope in wards. Tailored therapies for cancers and rare diseases, developed abroad, reached European hospitals in trial batches. Waiting lists filled within days. Health ministers queued for joint procurement, and Brussels promised the treatments would run on European data infrastructure, with patient data staying inside the Union.

The promise outran the capacity. Inference stacks, planning tools and the control software behind the new protocols were licensed from American labs, metered in dollars and subject to export paperwork. Hospital managers learned that scaling prescriptions meant scaling foreign compute bills. Editorials that had hailed cures turned to questions about who decided who got treated.

At the same time, the factory floor changed. Cheap, capable humanoids from Chinese supply chains appeared in logistics hubs in Rotterdam, Łódź and Lyon, leased with American fleet-management software. They stacked, carried, and cleared. Within months, videos circulated of the same platforms carrying weapons on foreign test ranges. Unions that had struck over clinic outages now marched over warehouse layoffs. Mayors who had begged for grid connections for data centres faced counter-demands to halt automation permits.

Brussels answered with a trust programme: EU-bought therapies, European hosting, labels for trustworthy clinical AI, money for hospital upgrades repurposed from old recovery loans. Health ministers endorsed it; finance ministers sulked. Permitting for gigafactories idled on low burn while lawyers stretched the draft agent gate to cover embodied control systems.

The containment work from autumn held where it had been built. Power stayed on, ports moved, and hospitals that had taken surge-team advice recovered faster from phishing waves. But the sense of exposure deepened: cures that proved dependence, robots that proved vulnerability. Relief and resentment arrived together, and resentment was louder.
```

## Raw response

```
Autumn's automated ransomware sweep via a compromised enterprise component hit municipalities, hospitals and logistics in several states, forcing paper systems and delaying welfare; attribution stalled. Cyber agency surge teams contained it, with power and ports holding from prior shielding while unshielded clinics fell; two audit-resistant capitals admitted help after cost haggling. A foreign low-oversight engineering demo then made EU factory plans and draft agent checks look undersized; Brussels narrowed the gate to critical-workflow systems and kept factories on low burn.

In spring, foreign tailored cancer and rare-disease therapies arrived in trial batches, filling waiting lists and prompting joint procurement pledges for EU-hosted delivery. Scaling exposed dependence on licensed US inference and control stacks, metered in dollars and export controls, turning cure coverage into rationing and compute-bill debates. Simultaneously, cheap Chinese humanoids leased with US fleet software spread in Rotterdam, Łódź and Lyon logistics, then appeared weaponized on foreign ranges, sparking union marches and demands to halt automation permits. Brussels launched a trust programme — EU-bought therapies, European hosting, trustworthy clinical AI labels, hospital upgrades from repurposed recovery loans — backed by health ministers, opposed by finance ministers; gigafactory permitting stayed idle while the agent gate was stretched to embodied systems. Autumn containment held for power, ports and retrofitted hospitals, but dependence deepened and public resentment outweighed relief, with trust slipping further.
```
